CClinicalTrials.gg
Not yet recruitingNCT07844798TORCHUpdated Sep 28, 2026

TORCH - Transdiagnostic Observation of Risk Factors, Craving and Health Behaviours in Psychiatric Patients

An observational study in Psychiatric Disorders, sponsored by Jacobs University Bremen gGmbH. Not yet recruiting at 1 site in Germany. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-28.

Sponsored by Jacobs University Bremen gGmbH · Observational

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
250
Ages
18 Years and older
Sex
All
01

Study summary

Mental disorders are often accompanied by health-risk behaviours, psychiatric comorbidity, and reduced functioning. TORCH investigates transdiagnostic mechanisms underlying multiple health behaviour change in adult psychiatric patients, with a focus on nicotine dependence and smoking. Based on the Compensatory Carry-Over Action Model (CCAM), the project examines self-efficacy, motivation, stress regulation, coping, and social support in relation to psychiatric symptoms and rehabilitation outcomes. Using a multimethod, naturalistic observational design, quantitative and qualitative data will be collected in inpatient and day-care psychiatry to identify mechanisms that support health behaviour change and rehabilitation.

Read the detailed description

Abstract

TORCH - Transdiagnostic Observation of Risk Factors, Craving and Health Behaviours in Psychiatric Patients

Mental disorders are frequently associated with health-risk behaviours, complex comorbidity profiles, and limitations in functional participation. However, transdiagnostic approaches systematically investigating the relationships between psychiatric comorbidity, multiple health behaviour change, and rehabilitation-related outcomes remain limited.

The TORCH project therefore investigates psychological, clinical, and behavioural mechanisms associated with health behaviours, behaviour change processes, and rehabilitation outcomes in adult psychiatric patients. The central research questions are: Which transdiagnostic factors influence multiple health behaviour changes, and how are these factors associated with psychiatric comorbidities, rehabilitation motivation, functional recovery, and social participation?

A particular focus is placed on nicotine dependence and smoking behaviour as an exemplary health behaviour and their interactions with other health-related behaviours. Based on the Compensatory Carry-Over Action Model (CCAM), the study examines the extent to which shared self-regulatory processes, including self-efficacy, motivation for change, stress regulation, coping strategies, and social support, contribute to multiple behaviour change processes. Furthermore, the study investigates how psychiatric comorbidities and symptom severity influence these mechanisms and rehabilitation-related outcomes.

The study is designed as a multimethod, naturalistic observational study conducted in an inpatient and day-care psychiatric setting. Adult patients receiving treatment at the Department of Psychiatry and Psychotherapy, Kreiskrankenhaus Prignitz, will be included. Quantitative data collection comprises standardized clinical interviews, self-report questionnaires, and non-invasive assessment procedures. Measures include nicotine dependence and craving, transdiagnostic mechanisms (including stress and coping measures), psychiatric symptom severity, and rehabilitation-related variables. In addition, qualitative data will be collected through semi-structured individual interviews, a World Café format, and open-ended questions to explore individual experiences, barriers, and resources related to multiple health behaviour changes and rehabilitation processes.

The study duration is approximately 18 months. During the first three months, study preparation, training of the research team, and implementation of study procedures will be conducted. This will be followed by a pilot phase to evaluate the feasibility of the assessment procedures, the comprehensibility of the instruments, and the implementation of the qualitative data collection procedures, with adaptations made where necessary. From month 4 to month 13, participant recruitment and quantitative as well as qualitative data collection will take place. Months 14 to 16 will focus on data preparation, statistical analyses, and qualitative analyses. The final two months will be dedicated to integrating the findings, scientific dissemination, and deriving clinical implications.

02

Conditions studied

  • Psychiatric Disorders

Keywords

  • Tobacco Use Disorder
  • Smoking Cessation
  • Mental Disorders
  • Inpatients
  • Health Behavior
  • Psychiatric Rehabilitation
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The study includes adults with nicotine dependence receiving inpatient or day-care psychiatric treatment at the Department of Psychiatry and Psychotherapy, Kreiskrankenhaus Prignitz. Eligibility requires informed consent and sufficient German language proficiency, with exclusion of individuals whose acute clinical condition or impaired decisional capacity would preclude participation.

Inclusion criteria

Participants must:

be affected by nicotine dependence

Be 18 years of age or older.

Be currently receiving inpatient or day-care psychiatric treatment at the Department of Psychiatry and Psychotherapy, Kreiskrankenhaus Prignitz.

Be capable of understanding study information and providing informed consent.

Possess sufficient German language proficiency to complete assessments and interviews.

Agree to participate voluntarily.

Exclusion criteria

Exclusion Criteria

Participants will be excluded if they:

Experience acute psychiatric symptoms that substantially impair informed consent capacity.

Are acutely intoxicated or experiencing severe withdrawal symptoms at the time of recruitment.

Demonstrate insufficient decisional capacity according to clinical assessment.

Do not have adequate German language proficiency.

Have any condition judged by the treating clinical team to render participation inappropriate or excessively burdensome.

04

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
250 participants (estimated)
Patient registry
No

Groups and cohorts

  • Patients from a psychiatric clinic at the Kreiskrankenhaus Prignitz

    Behavioral: person-centred interventions

Interventions

  • Behavioralperson-centred interventions

    The clinic treatment is a person-centred interventions that support smoking cessation, health promotion, rehabilitation participation, and long-term recovery among individuals with mental disorders.

05

What researchers measure

Primary outcomes

  1. BIS-15

    Barratt Impulsiveness Scale (BIS) is measuring behavioral inhibition (On a scale of 1 to 4: 1-rarely/never, 2-occasionally, 3-often, 4-almost always/always).

    Time frame: Timepoint 0 (baseline), Timepoint 1 (2-4 weeks later) and Timepoint 2 (approximately 1 month after discharge).

  2. FEVER

    Fragebogen zur Erfassung der Veränderungsbereitschaft (FEVER) is measuring readiness to hange / change motivation. On a scale of 1 to 5: 1-not at all applicable, 2-rather not applicable, 3-don't know/undecided, 4-rather applicable, 5-fully applicable.

    Time frame: Timepoint 0 (baseline), Timepoint 1 (2-4 weeks later) and Timepoint 2 (approximately 1 month after discharge).

  3. F-SozU K-14

    F-SozU K-14 is a Social Support Questionnaire. On a scale of 1 to 5: 1-not applicable, 2-rather not applicable, 3-partly applicable, 4-applicable, 5-exactly applicable.

    Time frame: Timepoint 0 (baseline), Timepoint 1 (2-4 weeks later) and Timepoint 2 (approximately 1 month after discharge).

  4. Fagerström Test

    Fagerström Test is measuring smoking behavior. Higher values mean higher consumption.

    Time frame: Timepoint 0 (baseline), Timepoint 1 (2-4 weeks later) and Timepoint 2 (approximately 1 month after discharge).

Secondary outcomes

  1. SF12

    SF12 is measuring functional status (description can be found here: Singh, A., Gnanalingham, K., Casey, A., \& Crockard, A. (2006). Quality of life assessment using the Short Form-12 (SF-12) questionnaire in patients with cervical spondylotic myelopathy: comparison with SF-36. Spine, 31(6), 639-643.).

    Time frame: Timepoint 0 (baseline), Timepoint 1 (2-4 weeks later) and Timepoint 2 (approximately 1 month after discharge).

  2. BSI-18

    BSI-18 Is a Brief-Symptom Inventory. On a scale of 1 to 4: 1-not at all, 2, 3, 4-very strongly.

    Time frame: Timepoint 0 (baseline), Timepoint 1 (2-4 weeks later) and Timepoint 2 (approximately 1 month after discharge).

  3. BIP-Q

    BIP-Q is measuring the illness perceptions. On a scale of 0 to 10: 0-no impairment at all, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10-very severe impairment.

    Time frame: Timepoint 0 (baseline), Timepoint 1 (2-4 weeks later) and Timepoint 2 (approximately 1 month after discharge).

  4. PSS

    PSS is measuring perceived stress. On a scale of 1 to 5: 1-never, 2-almost never, 3-sometimes, 4-quite often, 5-very often.

    Time frame: Timepoint 0 (baseline), Timepoint 1 (2-4 weeks later) and Timepoint 2 (approximately 1 month after discharge).

  5. CHB-Q

    CHB-Q (Compensatory Health Beliefs) is a subscale for substance use. On a scale of 1 to 5: 1-strongly disagree, 2, 3, 4, 5-strongly agree.

    Time frame: Timepoint 0 (baseline), Timepoint 1 (2-4 weeks later) and Timepoint 2 (approximately 1 month after discharge).

  6. QSU-G

    QSU-G is a questionnaire on Smoking Urges. On a scale of 1 to 7: 1-completely true, 2, 3, 4, 5, 6, 7-not true at all.

    Time frame: Timepoint 0 (baseline), Timepoint 1 (2-4 weeks later) and Timepoint 2 (approximately 1 month after discharge).

  7. BDI2

    Beck Depression Index.

    Time frame: Timepoint 0 (baseline), Timepoint 1 (2-4 weeks later) and Timepoint 2 (approximately 1 month after discharge).

  8. CHQ

    Compensatory Health Belief Questionnaire (Subscale Substance Use). On a scale of 1 to 5: 1-strongly disagree, 2, 3, 4, 5-strongly agree.

    Time frame: Timepoint 0 (baseline), Timepoint 1 (2-4 weeks later) and Timepoint 2 (approximately 1 month after discharge).

Other outcomes

  1. Rehabilitation Intentions

    Rehabilitation Intentions is measuring Rehabilitation-related intentions and willingness to apply for medical rehabilitation were assessed using self-report items.

    Time frame: Timepoint 0 (baseline), Timepoint 1 (2-4 weeks later) and Timepoint 2 (approximately 1 month after discharge).

06

Study locations

1 site
  • Kreiskrankenhaus Prignitz gemeinnützige GmbH
    Perleberg, 19348, Germany
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT07844798
Lead sponsor
Jacobs University Bremen gGmbH
Collaborators
Kreiskrankenhaus Prignitz gGmbH, Hamburg University of Applied Sciences
Responsible party
Prof. Dr. Sonia Lippke (Head of Health Psychology & Behavioral Medicine Unit, Jacobs University Bremen gGmbH) — Principal investigator
First posted
Sep 28, 2026
Start date
Oct 1, 2026 (estimated)
Primary completion
Dec 31, 2029 (estimated)
Completion
Dec 31, 2030 (estimated)
Last update
Sep 28, 2026

Study contacts

Marc Warnecke, Dr.
Contact
m.warnecke@krankenhaus-prignitz.de
+493876 30 - 3200
Robin Rinn, Dr.
Contact
rrinn@constructor.university
+494212004730
Sonia Lippke, Dr.
study director · Constructor University Bremen gGmbH

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion